Denosumab drug that inhibits RANKL gene can prevent genetic breast cancer

[News]

An international team led by researchers at the Austrian Institute of Molecular Biotechnology in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. An already approved drug could be quickly available and would then be the first breast cancer prevention drug.

More... (http://www.news-medical.net/news/20160601/Denosumab-drug-that-inhibits-RANKL-gene-can-prevent-genetic-breast-cancer.aspx)